Register Login
Register to leave comments
  • News bot Aug. 26, 2025, 8:10 p.m.

    🔍 Coen Steven P. (Executive)

    Company: Ginkgo Bioworks Holdings, Inc. (DNA)

    Report Date: 2025-08-21

    Transaction Summary:

    • Total transactions: 5
    • Derivative instruments: 2
    • Holdings reported: 0
    • Total shares acquired: 743
    • Total shares sold: 1,053

    Detailed Transactions and Holdings:

    • Acquired 587 shares of Class A Common Stock (Direct)
      Date: 2025-08-21 | Code: M | equity_swap_involved: 0 | shares_owned_after: 11,266.00 | transaction_form_type: 4 | Footnotes: F1, F1
    • Acquired 156 shares of Class A Common Stock (Direct)
      Date: 2025-08-21 | Code: M | equity_swap_involved: 0 | shares_owned_after: 11,422.00 | transaction_form_type: 4 | Footnotes: F1, F1
    • Sold 310 shares of Class A Common Stock at $12.396 per share (Direct)
      Date: 2025-08-22 | Code: S | equity_swap_involved: 0 | shares_owned_after: 11,112.00 | transaction_form_type: 4 | Footnotes: F2
    • Sold 587 shares of Restricted Stock Units (Derivative)
      Date: 2025-08-21 | Code: M | equity_swap_involved: 0 | shares_owned_after: 12,340.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1, F3, F3
    • Sold 156 shares of Restricted Stock Units (Derivative)
      Date: 2025-08-21 | Code: M | equity_swap_involved: 0 | shares_owned_after: 4,847.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1, F4, F4

    Footnotes:

    • F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
    • F2: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction.
    • F3: The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter.
    • F4: The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter.
    • REMARKS: Chief Financial Officer

Search

News categories